Tradestie Institutional Equity Comparison Engine · Market Close Nov 20, 2026
KORE vs BBLG: Which Stock Is the Better Buy Now?
Deterministic 6-pillar institutional evaluation across valuation multiples, TTM & multi-year operating margins, cash generation, options IV skew, and supply-chain moat.
KORE Wins Head-to-Head Institutional Verdict (5–1 across 6 Pillars · 4–4 Matrix Metrics)
KORE Overall Winner
6-Pillar Tally: KORE 5 – 1 BBLG
Matrix Metrics: KORE 4 – 4 BBLG
As of Nov 20, 2026, KORE Group Holdings, Inc. (KORE) is the stronger overall head-to-head candidate over Bone Biologics Corp (BBLG) in the Tradestie Institutional Equity Comparison Engine, winning 4–4 core matrix metrics and 5–1 across our 6-pillar institutional scorecard (led by Valuation Multiples, Growth & Scale, Balance Sheet & Cash Flow). KORE carries a Unified Composite Score of 55.3/100 (HOLD) at $9.25 (N/M Forward P/E, -6.2% operating margin), whereas BBLG carries 44.8/100 (HOLD) at $0.27 (N/M Forward P/E, 0.0% operating margin).
- Technical & Structure Timing Caution: KORE trades in a Markup technical trend (UNCLASSIFIED options phase, RSI 50.5); meanwhile BBLG is in a short-term Weinstein Markdown pullback below its falling 50-day moving average and Breakdown options structure phase (RSI 30.9). Short-term Markdown, Distribution, or Breakdown phases signal active supply overhead rather than bullish technical support — disciplined entries typically wait for price to reclaim the 20/50-day moving average.
Executive Snapshot Side-by-Side Composite Ratings & Technical Regime
Ask Alpha AI About KORE vs BBLG
KORE
Head-to-Head Winner
KORE Group Holdings, Inc.
$9.25
-0.11% 1D
Market Cap
$163.0M
TTM Revenue
$280M
Forward P/E
N/M
Beta / 30D Vol
-0.15β · 29% Vol
Unified Composite Score
55.3
HOLD
Tech 40.0
Fund 48.0
Flow 50.0
Mom 60.0
Weinstein Technical Phase
Markup · Hold / add on dips
BBLG
Bone Biologics Corp Common Stock
$0.27
-2.4% 1D
Market Cap
$932,329
TTM Revenue
N/A
Forward P/E
N/M
Beta / 30D Vol
0.97β · 102% Vol
Unified Composite Score
44.8
HOLD
Tech 33.0
Fund 48.0
Flow 50.0
Mom 64.0
Weinstein Technical Phase
Markdown · Sell / avoid
6-Pillar Scorecard Institutional Category Breakdown (KORE 5 – 1 BBLG)
1. Valuation Multiples
KORE
Forward P/E
N/M
N/M
Trailing P/E
N/M
N/M
PEG Ratio
N/M
N/M
EV / Revenue
1.5x
N/M
2. Growth & Scale
KORE
Revenue Growth (YoY)
-8.8%
+0.0%
Earnings Growth (YoY)
+0.0%
+0.0%
TTM Revenue (USD)
$280M
N/A
Market Cap
$163.0M
$932,329
3. Profitability & Quality
BBLG
Gross Margin
56.5%
N/A
Operating Margin
-6.2%
0.0%
Net Profit Margin
-27.4%
0.0%
Return on Equity (ROE)
-336.9%
-47.5%
4. Balance Sheet & Cash Flow
KORE
Cash Generation (TTM)
$11M
N/A
Cash Flow Margin
3.9%
N/A
Net Cash / Leverage
$270M Net Debt
$1.76 Book/Sh · -47.5% ROE
Dividend Yield
None (0.00%)
None (0.00%)
5. Options & Positioning
KORE
Options Structure Phase
UNCLASSIFIED
BREAKDOWN
Current IV / %ile
N/A (N/A)
N/A (N/A)
Put/Call OI Skew
N/A
N/A
OBV Trend / Tech Phase
NEUTRAL · Markup
ACCUMULATION · Markdown
6. R&D & Supply-Chain Moat
KORE
OpEx & R&D Intensity
62.7% of Rev ($175M)
N/A
90D R&D Disclosures
0 papers
0 papers
Competitive Moat
Cyclical / Execution-Driven Positioning
Cyclical / Execution-Driven Positioning
Supply-Chain Role
Telecom Services Operator
Biotechnology Operator
Core Matrix Head-to-Head Valuation, Margin, Cash Flow & Risk Table
Core Matrix Wins: KORE (4) vs BBLG (4)| Institutional Metric | KORE | BBLG | Criterion | Row Edge |
|---|---|---|---|---|
| Market Capitalization | $163.0M | $932,329 | KORE | |
| Trailing P/E Ratio | N/M | N/M | Tie | |
| Forward P/E Ratio | N/M | N/M | Tie | |
| Revenue Growth (YoY) | -8.8% | +0.0% | BBLG | |
| Operating Margin (TTM) | -6.2% | 0.0% | BBLG | |
| Net Profit Margin | -27.4% | 0.0% | BBLG | |
| Return on Equity (ROE) | -336.9% | -47.5% | BBLG | |
| 52-Week Range Position | 93% ($2–$10) | 0% ($0–$2) | KORE | |
| Beta / 30D Volatility | -0.15β · 29% Vol | 0.97β · 102% Vol | KORE | |
| Unified Institutional Score | 55.3 / 100 (HOLD) | 44.8 / 100 (HOLD) | KORE | |
| Trailing 12M Revenue (USD) | $280M | N/A | Scale | |
| Gross Profit Margin (TTM) | 56.5% | N/A | Quality | |
| PEG Ratio & EV / Revenue | N/M PEG · 1.5x EV/Rev | N/M PEG · N/M EV/Rev | Valuation | |
| Cash Flow & Balance Sheet | $11M ($270M Net Debt) | N/A ($1.76 Book/Sh · -47.5% ROE) | Solvency |
Momentum Normalized Relative Price Performance (1M · 3M · 6M · 1Y)
1M Horizon
KORE +24.57 pp
3M Horizon
KORE +20.62 pp
6M Horizon
KORE +121.32 pp
1Y Horizon
KORE +146.31 pp
Financial Trajectory Multi-Year Annual Revenue & Operating Margin Trajectory (USD)
| Period | KORE Revenue | BBLG Revenue | KORE Op. Margin | BBLG Op. Margin | Margin Leader |
|---|---|---|---|---|---|
| FY2019 | $170M | $1.07B | -7.0% | -0.2% | BBLG |
| FY2020 | $210M | $1.07B | -4.5% | -0.1% | BBLG |
| FY2021 | $250M | N/A | -6.3% | N/A | KORE |
| FY2022 | $270M | N/A | -31.8% | N/A | KORE |
| FY2023 | $280M | N/A | -42.9% | N/A | KORE |
| FY2024 | $290M | N/A | -35.9% | N/A | KORE |
| FY2025 | $290M | N/A | -4.4% | N/A | KORE |
Options Positioning Implied Volatility, Put/Call Skew & Dealer Gamma Corridor
Live Options Phase Tracker
KORE
UNCLASSIFIED
Current IV
N/A
IV Percentile
N/A
Put/Call OI Skew
N/A
IV Regime
Unclassified
Put Wall Floor
Pro Only
Call Wall Magnet
Pro Only
Net Delta Signal
NEUTRAL
OBV Flow
NEUTRAL
Exact KORE Put/Call Gamma Wall strikes & dealer pinning corridor require Tradestie Pro.
Unlock 14-Day Free Trial →
BBLG
BREAKDOWN
Current IV
N/A
IV Percentile
N/A
Put/Call OI Skew
N/A
IV Regime
Unclassified
Put Wall Floor
Pro Only
Call Wall Magnet
Pro Only
Net Delta Signal
NEUTRAL
OBV Flow
ACCUMULATION
Exact BBLG Put/Call Gamma Wall strikes & dealer pinning corridor require Tradestie Pro.
Unlock 14-Day Free Trial →
Moat & R&D Supply-Chain Positioning, Bottleneck Moat & R&D Velocity
Corporate R&D & Foundry Leaderboard
KORE Moat Profile
Cyclical / Execution-Driven Positioning
Telecom Services Operator
OpEx & R&D Reinvestment
62.7% of Rev ($175M)
90D Engineering Disclosures
0 Published
BBLG Moat Profile
Cyclical / Execution-Driven Positioning
Biotechnology Operator
OpEx & R&D Reinvestment
N/A
90D Engineering Disclosures
0 Published
Investor FAQ KORE vs BBLG Key Questions & Quantitative Answers
As of Nov 20, 2026, KORE Group Holdings, Inc. (KORE) is the stronger overall head-to-head candidate over Bone Biologics Corp (BBLG) in the Tradestie Institutional Equity Comparison Engine, winning 4–4 core matrix metrics and 5–1 across our 6-pillar institutional scorecard (led by Valuation Multiples, Growth & Scale, Balance Sheet & Cash Flow). KORE carries a Unified Composite Score of 55.3/100 (HOLD) at $9.25 (N/M Forward P/E, -6.2% operating margin), whereas BBLG carries 44.8/100 (HOLD) at $0.27 (N/M Forward P/E, 0.0% operating margin). Technical & Structure Timing Caution: KORE trades in a Markup technical trend (UNCLASSIFIED options phase, RSI 50.5); meanwhile BBLG is in a short-term Weinstein Markdown pullback below its falling 50-day moving average and Breakdown options structure phase (RSI 30.9). Short-term Markdown, Distribution, or Breakdown phases signal active supply overhead rather than bullish technical support — disciplined entries typically wait for price to reclaim the 20/50-day moving average.
KORE leads the Growth & Scale pillar: KORE posts -8.8% YoY revenue growth and +0.0% YoY earnings growth on $280M TTM revenue (56.5% gross margin, -6.2% operating margin), compared with BBLG at +0.0% YoY revenue growth and +0.0% YoY earnings growth on N/A TTM revenue (N/A gross margin, 0.0% operating margin). Across the 7-period historical trajectory (FY2019 to FY2025), KORE cumulative revenue shifted +70.6% while BBLG shifted +0.0%. In operating R&D and SG&A reinvestment, KORE deploys 62.7% of Rev ($175M) (0 90-day corporate R&D disclosures) versus N/A (0 disclosures) for BBLG.
KORE screens cheaper on headline valuation multiples. KORE trades at N/M Forward P/E, N/M Trailing P/E, N/M PEG, and 1.5x EV/Revenue (3.9% FCF margin), whereas BBLG trades at N/M Forward P/E, N/M Trailing P/E, N/M PEG, and N/M EV/Revenue (unreported cash flow margin). Multiples above 150x or negative earnings denominators are marked N/M to avoid distorted accounting comparisons; weigh lower Forward P/E and PEG against KORE (-336.9% ROE) versus BBLG (-47.5% ROE) capital efficiency.
In options market volatility and institutional positioning, KORE carries N/A implied volatility (N/A, Unclassified), unclassified Put/Call open interest, NEUTRAL on-balance volume, and sits in an UNCLASSIFIED options structure phase (-0.15β · 29% Vol realized risk). By comparison, BBLG carries N/A implied volatility (N/A, Unclassified), unclassified Put/Call open interest, ACCUMULATION on-balance volume, and sits in a BREAKDOWN options structure phase (0.97β · 102% Vol realized risk).
Cross-Compare 1-Click Peer Rivalries & Single-Stock Research
Launch Custom Ticker Comparison →
BBLG vs KORE · Reverse Pair
KORE vs ANGH
· Sector Peer
BBLG vs REVB
· Sector Peer
INTC vs AMD
· x86 & Data Center CPU
NVDA vs AMD
· AI Accelerators
TSM vs ASML
· Foundry & Lithography
MSFT vs GOOGL
· Hyperscale Cloud & AI
AAPL vs META
· Consumer Ecosystem
LLY vs NVO
· GLP-1 Biopharma
AVGO vs MRVL
· Custom ASIC & Networking
VRT vs ETN
· AI Power & Thermal